Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques

Virology

Volumn 381, Issue 1, 2008, Pages 89-97

  Chen, Yunxin ^a   Liu, Li ^b   Wei, Qiang ^a   Zhu, Hua ^a   Jiang, Hong ^a   Tu, Xinming ^a   Qin, Chuan ^a   Chen, Zhiwei ^b  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ACE2; Chinese rhesus monkey; Lung pathogenesis; SARS; SARS CoV

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHINESE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS ENTRY; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LUNG; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDYL-DIPEPTIDASE A; SARS VIRUS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS INTERNALIZATION;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES; SARS CORONAVIRUS;

EID: 54149102984     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.016     Document Type: Article

References (41)

1. Chan V.S., Chan K.Y., Chen Y., Poon L.L., Cheung A.N., Zheng B., Chan K.H., Mak W., Ngan H.Y., Xu X., Screaton G., Tam P.K., Austyn J.M., Chan L.C., Yip S.P., Peiris M., Khoo U.S., and Lin C.L. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat. Genet. 38 1 (2006) 38-46
2. Chen Z., Zhou P., Ho D.D., Landau N.R., and Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71 4 (1997) 2705-2714
3. Chen Z., Gettie A., Ho D.D., and Marx P.A. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 246 1 (1998) 113-124
4. Chen Z., Kwon D., Jin Z., Monard S., Telfer P., Jones M.S., Lu C.Y., Aguilar R.F., Ho D.D., and Marx P.A. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J. Exp. Med. 188 11 (1998) 2057-2065
5. Chen Z., Zhang L., Qin C., Ba L., Yi C.E., Zhang F., Wei Q., He T., Yu W., Yu J., Gao H., Tu X., Gettie A., Farzan M., Yuen K.Y., and Ho D.D. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. 79 5 (2005) 2678-2688
6. Chiu R.W., Tang N.L., Hui D.S., Chung G.T., Chim S.S., Chan K.C., Sung Y.M., Chan L.Y., Tong Y.K., Lee W.S., Chan P.K., and Lo Y.M. ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin. Chem. 50 9 (2004) 1683-1686
7. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., Oliveira-dos-Santos A.J., da Costa J., Zhang L., Pei Y., Scholey J., Ferrario C.M., Manoukian A.S., Chappell M.C., Backx P.H., Yagil Y., and Penninger J.M. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 6891 (2002) 822-828
8. Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J., Wang H., Shen H., Qiu L., Li Z., Geng J., Cai J., Han H., Li X., Kang W., Weng D., Liang P., and Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203 2 (2004) 622-630
9. Donnelly C.A., Fisher M.C., Fraser C., Ghani A.C., Riley S., Ferguson N.M., and Anderson R.M. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet. Infect. Dis. 4 11 (2004) 672-683
10. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., and Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 20 (2003) 1967-1976
11. Franks T.J., Chong P.Y., Chui P., Galvin J.R., Lourens R.M., Reid A.H., Selbs E., McEvoy C.P., Hayden C.D., Fukuoka J., Taubenberger J.K., and Travis W.D. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 34 8 (2003) 743-748
12. Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G.J., and van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203 2 (2004) 631-637
13. Han D.P., Penn-Nicholson A., and Cho M.W. Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology 350 1 (2006) 15-25
14. He L., Ding Y., Zhang Q., Che X., He Y., Shen H., Wang H., Li Z., Zhao L., Geng J., Deng Y., Yang L., Li J., Cai J., Qiu L., Wen K., Xu X., and Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 210 3 (2006) 288-297
15. Hofmann H., Simmons G., Rennekamp A.J., Chaipan C., Gramberg T., Heck E., Geier M., Wegele A., Marzi A., Bates P., and Pohlmann S. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J. Virol. 80 17 (2006) 8639-8652
16. Huang I.C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., Vasilieva N., Dermody T.S., Harrison S.C., Dormitzer P.R., Farzan M., Rottier P.J., and Choe H. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281 6 (2006) 3198-3203
17. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M.A., Fukamizu A., Hui C.C., Hein L., Uhlig S., Slutsky A.S., Jiang C., and Penninger J.M. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 7047 (2005) 112-116
18. Itoyama S., Keicho N., Hijikata M., Quy T., Phi N.C., Long H.T., Ha le D., Ban V.V., Matsushita I., Yanai H., Kirikae F., Kirikae T., Kuratsuji T., and Sasazuki T. Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population. Am. J. Med. Genet. A. 136 1 (2005) 52-57
19. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., and Penninger J.M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 8 (2005) 875-879
20. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D., Laman J.D., de Jong T., van Doornum G., Lim W., Ling A.E., Chan P.K., Tam J.S., Zambon M.C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.C., Stohr K., Peiris J.S., and Osterhaus A.D. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362 9380 (2003) 263-270
21. Law H.K., Cheung C.Y., Ng H.Y., Sia S.F., Chan Y.O., Luk W., Nicholls J.M., Peiris J.S., and Lau Y.L. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106 7 (2005) 2366-2374
22. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 6965 (2003) 450-454
23. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., Zhong N., and Lu P.Y. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11 9 (2005) 944-951
24. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 5742 (2005) 1864-1868
25. Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., and Farzan M. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO. J. 24 8 (2005) 1634-1643
26. Li F., Berardi M., Li W., Farzan M., Dormitzer P.R., and Harrison S.C. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J. Virol. 80 14 (2006) 6794-6800
27. Liu L., Fang Q., Deng F., Wang H., Yi C.E., Ba L., Yu W., Lin R.D., Li T., Hu Z., Ho D.D., Zhang L., and Chen Z. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J. Virol. 81 9 (2007) 4694-4700
28. Mossel E.C., Huang C., Narayanan K., Makino S., Tesh R.B., and Peters C.J. Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J. Virol. 79 6 (2005) 3846-3850
29. Nicholls J.M., Poon L.L., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., Chu C.M., Hui P.K., Mak K.L., Lim W., Yan K.W., Chan K.H., Tsang N.C., Guan Y., Yuen K.Y., and Peiris J.S. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361 9371 (2003) 1773-1778
30. Osterhaus A.D., Fouchier R.A., and Kuiken T. The aetiology of SARS: Koch's postulates fulfilled. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359 1447 (2004) 1081-1082
31. Peiris J.S., Chu C.M., Cheng V.C., Chan K.S., Hung I.F., Poon L.L., Law K.I., Tang B.S., Hon T.Y., Chan C.S., Chan K.H., Ng J.S., Zheng B.J., Ng W.L., Lai R.W., Guan Y., and Yuen K.Y. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 9371 (2003) 1767-1772
32. Peiris J.S., Yuen K.Y., Osterhaus A.D., and Stohr K. The severe acute respiratory syndrome. N. Engl. J. Med. 349 25 (2003) 2431-2441
33. Peiris J.S., Guan Y., and Yuen K.Y. Severe acute respiratory syndrome. Nat. Med. 10 12 Suppl (2004) S88-97
34. Qin C., Wang J., Wei Q., She M., Marasco W.A., Jiang H., Tu X., Zhu H., Ren L., Gao H., Guo L., Huang L., Yang R., Cong Z., Wang Y., Liu Y., Sun Y., Duan S., Qu J., Chen L., Tong W., Ruan L., Liu P., Zhang H., Zhang J., Liu D., Liu Q., Hong T., and He W. An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J. Pathol. 206 3 (2005) 251-259
35. Riley S., Fraser C., Donnelly C.A., Ghani A.C., Abu-Raddad L.J., Hedley A.J., Leung G.M., Ho L.M., Lam T.H., Thach T.Q., Chau P., Chan K.P., Lo S.V., Leung P.Y., Tsang T., Ho W., Lee K.H., Lau E.M., Ferguson N.M., and Anderson R.M. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300 5627 (2003) 1961-1966
36. Rowe T., Gao G., Hogan R.J., Crystal R.G., Voss T.G., Grant R.L., Bell P., Kobinger G.P., Wivel N.A., and Wilson J.M. Macaque model for severe acute respiratory syndrome. J. Virol. 78 20 (2004) 11401-11404
37. Shieh W.J., Hsiao C.H., Paddock C.D., Guarner J., Goldsmith C.S., Tatti K., Packard M., Mueller L., Wu M.Z., Rollin P., Su I.J., and Zaki S.R. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum. Pathol. 36 3 (2005) 303-309
38. Sims A.C., Baric R.S., Yount B., Burkett S.E., Collins P.L., and Pickles R.J. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J. Virol. 79 24 (2005) 15511-15524
39. To K.F., Tong J.H., Chan P.K., Au F.W., Chim S.S., Chan K.C., Cheung J.L., Liu E.Y., Tse G.M., Lo A.W., Lo Y.M., and Ng H.K. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J. Pathol. 202 2 (2004) 157-163
40. Tse G.M., To K.F., Chan P.K., Lo A.W., Ng K.C., Wu A., Lee N., Wong H.C., Mak S.M., Chan K.F., Hui D.S., Sung J.J., and Ng H.K. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J. Clin. Pathol. 57 3 (2004) 260-265
41. Yi C.E., Ba L., Zhang L., Ho D.D., and Chen Z. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J. Virol. 79 18 (2005) 11638-11646